| The management of desmoid tumours: a joint global consensus-based guideline approach for adult and paediatric patients B Alman, S Attia, C Baumgarten, C Benson, JY Blay, S Bonvalot, ... European Journal of Cancer 127, 96-107, 2020 | 311 | 2020 |
| SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas F Le Loarer, S Watson, G Pierron, VT de Montpreville, S Ballet, N Firmin, ... Nature genetics 47 (10), 1200-1205, 2015 | 296 | 2015 |
| Transcriptomic definition of molecular subgroups of small round cell sarcomas S Watson, V Perrin, D Guillemot, S Reynaud, JM Coindre, M Karanian, ... The Journal of pathology 245 (1), 29-40, 2018 | 271 | 2018 |
| Pragmatic issues in biomarker evaluation for targeted therapies in cancer A De Gramont, S Watson, LM Ellis, J Rodón, J Tabernero, A De Gramont, ... Nature reviews Clinical oncology 12 (4), 197-212, 2015 | 210 | 2015 |
| Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients P Chaïbi, N Magné, S Breton, A Chebib, S Watson, JJ Duron, L Hannoun, ... Critical reviews in oncology/hematology 79 (3), 302-307, 2011 | 208 | 2011 |
| SMARCA4-deficient thoracic sarcomas: clinicopathologic study of 30 cases with an emphasis on their nosology and differential diagnoses R Perret, L Chalabreysse, S Watson, I Serre, S Garcia, F Forest, V Yvorel, ... The American Journal of Surgical Pathology 43 (4), 455-465, 2019 | 151 | 2019 |
| HIV-1 buds and accumulates in “nonacidic” endosomes of macrophages M Jouve, N Sol-Foulon, S Watson, O Schwartz, P Benaroch Cell host & microbe 2 (2), 85-95, 2007 | 151 | 2007 |
| Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide … A Lievre, A Turpin, I Ray-Coquard, K Le Malicot, J Thariat, G Ahle, ... European Journal of Cancer 141, 62-81, 2020 | 143 | 2020 |
| ETV4 is a useful marker for the diagnosis of CIC-rearranged undifferentiated round-cell sarcomas: a study of 127 cases including mimicking lesions S Le Guellec, V Velasco, G Pérot, S Watson, F Tirode, JM Coindre Modern Pathology 29 (12), 1523-1531, 2016 | 123 | 2016 |
| Clinicopathologic features of CIC-NUTM1 sarcomas, a new molecular variant of the family of CIC-fused sarcomas F Le Loarer, D Pissaloux, S Watson, C Godfraind, L Galmiche-Rolland, ... The American journal of surgical pathology 43 (2), 268-276, 2019 | 112 | 2019 |
| A role for CD81 on the late steps of HIV-1 replication in a chronically infected T cell line B Grigorov, V Attuil-Audenis, F Perugi, M Nedelec, S Watson, C Pique, ... Retrovirology 6, 1-16, 2009 | 104 | 2009 |
| A druggable copper-signalling pathway that drives inflammation S Solier, S Müller, T Cañeque, A Versini, A Mansart, F Sindikubwabo, ... Nature 617 (7960), 386-394, 2023 | 69 | 2023 |
| A prospective, descriptive cohort study of malignant wound characteristics and wound care strategies in patients with breast cancer. I Fromantin, S Watson, A Baffie, A Rivat, MC Falcou, I Kriegel, ... Ostomy/wound management 60 (6), 38-48, 2014 | 57 | 2014 |
| Combined HER2 analysis of biopsies and surgical specimens to optimize detection of trastuzumab-eligible patients in eso-gastric adenocarcinoma: a GERCOR study S Watson, P Validire, P Cervera, N Zorkani, A Scriva, F Lemay, ... Annals of oncology 24 (12), 3035-3039, 2013 | 47 | 2013 |
| Bacterial floras and biofilms of malignant wounds associated with breast cancers I Fromantin, D Seyer, S Watson, F Rollot, J Elard, MC Escande, ... Journal of Clinical Microbiology 51 (10), 3368-3373, 2013 | 44 | 2013 |
| PAX3-FOXO1 transgenic zebrafish models identify HES3 as a mediator of rhabdomyosarcoma tumorigenesis GC Kendall, S Watson, L Xu, CA LaVigne, W Murchison, D Rakheja, ... Elife 7, e33800, 2018 | 40 | 2018 |
| Targeting the VEGF pathway in osteosarcoma T Assi, S Watson, B Samra, E Rassy, A Le Cesne, A Italiano, O Mir Cells 10 (5), 1240, 2021 | 33 | 2021 |
| Sonic Hedgehog signaling pathway: from embryology to molecular targeted therapies S Watson, C Serrate, S Vignot Bulletin du cancer 97 (12), 1477-1483, 2010 | 23 | 2010 |
| Oxaliplatin, 5-fluorouracil and nab-paclitaxel as perioperative regimen in patients with resectable gastric adenocarcinoma: a GERCOR phase II study (FOXAGAST) S Watson, C De La Fouchardiere, S Kim, R Cohen, JB Bachet, ... European Journal of Cancer 107, 46-52, 2019 | 17 | 2019 |
| Oncogenic chimeric transcription factors drive tumor-specific transcription, processing, and translation of silent genomic regions J Vibert, O Saulnier, C Collin, F Petit, KJE Borgman, J Vigneau, M Gautier, ... Molecular Cell 82 (13), 2458-2471. e9, 2022 | 16 | 2022 |
